“…Vpr is an accessory gene product of the human immunodeficiency virus type 1 (HIV-1) and a small 15-kDa protein with multiple biological functions, including splicing regulation [1][2][3], support of virus release [4], nuclear import of the viral preintegration complex in macrophages [5][6][7], enhanced expression and processing of the envelope glycoprotein in macrophages [8][9][10], sustaining interleukin 6 expression to enhance HIV-1 replication [11], antagonism of exonuclease 1-and helicase-like transcription factor-mediated restriction in T cells through degradation of these proteins [12][13][14][15], regulation of apoptosis in both a positive and negative manner, and the induction of cell cycle arrest at the G2 phase in dividing cells [16][17][18][19][20][21]. Multiple functions of Vpr are exerted through interactions with various host factors, such as DNA damage-binding protein 1 (DDB1)-and cullin 4 (CUL4)-associated factor 1 (DCAF1), spliceosome-associated protein 145, p300, synthetic lethal of unknown (X) function 4 (SLX4), protein arginine N-methyltransferase 5, importin α, mini-chromosome maintenance protein10, and coiled-coil domain-containing-137 (CCDC137) [2,6,7,13,20,[22][23][24][25][26][27]. The induction of G2 arrest is likely an important function for efficient viral replication because the ability of Vpr to cause cell cycle blockade is well conserved among primate lentiviruses [28,29].…”